Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
作者信息
Olmedo M, Reigadas E, Valerio M, Vázquez-Cuesta S, Pajares J A, Matilla A, Muñoz P, Bouza E
机构信息
María Olmedo Samperio. Servicio de Microbiología Clínica y Enfermedades Infecciosas. Hospital General Universitario Gregorio Marañón. Madrid, Spain.
Emilio Bouza Santiago, Instituto de Investigación Sanitaria Gregorio Marañón. Madrid, Spain.
出版信息
Rev Esp Quimioter. 2019 Apr;32(2):205-207. Epub 2019 Mar 8.
Abstract
摘要
相似文献
1
Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?对于肝硬化患者复发性艰难梭菌感染进行粪便微生物群移植是否合理？
Rev Esp Quimioter. 2019 Apr;32(2):205-207. Epub 2019 Mar 8.
2
Fecal microbiota transplantation for recurrent infection.粪便微生物群移植治疗复发性感染。
CMAJ. 2018 Jun 18;190(24):E746. doi: 10.1503/cmaj.171454.
3
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.粪便微生物群移植治疗合并炎症性肠病的复发性艰难梭菌感染患者
Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016.
4
Immune Thrombocytopenia Caused by Fecal Microbial Transplantation in a Patient With Severe Recurrent Clostridium difficile Infection.粪便微生物移植导致的免疫性血小板减少症在一名严重复发性艰难梭菌感染患者中的发生情况
J Clin Gastroenterol. 2015 Nov-Dec;49(10):888-9. doi: 10.1097/MCG.0000000000000404.
5
Non-invasive fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient presenting with hypertensive disorder post interventionem.干预后出现高血压疾病的患者复发性艰难梭菌感染的非侵入性粪便微生物群移植
Z Gastroenterol. 2016 Oct;54(10):1143-1146. doi: 10.1055/s-0042-110795. Epub 2016 Sep 19.
6
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects].[复发性艰难梭菌感染中的粪便微生物群移植。框架与药物制剂方面]
Ann Pharm Fr. 2015 Sep;73(5):323-31. doi: 10.1016/j.pharma.2015.02.004. Epub 2015 Mar 29.
7
A case of toxic megacolon caused by clostridium difficile infection and treated with fecal microbiota transplantation.1例由艰难梭菌感染引起的中毒性巨结肠并接受粪便微生物群移植治疗的病例。
Gut Liver. 2015 Mar;9(2):247-50. doi: 10.5009/gnl14152.
8
Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis.非达霉素与粪便微生物群移植治疗重度艰难梭菌结肠炎
Am J Ther. 2019 Jan/Feb;26(1):e115-e117. doi: 10.1097/MJT.0000000000000573.
9
Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit.粪便微生物群移植：重症监护病房中艰难梭菌感染的治疗选择
J Intensive Care Med. 2016 Oct;31(9):577-86. doi: 10.1177/0885066615594344. Epub 2015 Jul 3.
10
Fecal Microbiota Transplantation: Just a Fancy Trend?粪便微生物群移植：只是一种新奇的潮流吗？
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):4-7. doi: 10.1097/MPG.0000000000000816.
引用本文的文献
1
The gut-liver axis in hepatobiliary diseases.肝胆疾病中的肠-肝轴
Inflamm Regen. 2024 Jan 8;44(1):2. doi: 10.1186/s41232-023-00315-0.
2
Fecal Microbiota Transplantation in Liver Cirrhosis.粪便微生物群移植治疗肝硬化
Biomedicines. 2023 Oct 30;11(11):2930. doi: 10.3390/biomedicines11112930.
3
Gut-liver axis: barriers and functional circuits.肠-肝轴：屏障和功能回路。
Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):447-461. doi: 10.1038/s41575-023-00771-6. Epub 2023 Apr 21.
4
Identifying microbe-disease association based on graph convolutional attention network: Case study of liver cirrhosis and epilepsy.基于图卷积注意力网络识别微生物与疾病的关联：以肝硬化和癫痫为例
Front Neurosci. 2023 Jan 19;16:1124315. doi: 10.3389/fnins.2022.1124315. eCollection 2022.
5
Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy.失代偿期肝硬化患者的粪便微生物群移植：安全性和有效性的系统评价
Antibiotics (Basel). 2022 Jun 23;11(7):838. doi: 10.3390/antibiotics11070838.
6
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.粪便微生物群移植治疗肝硬化患者肝性脑病和艰难梭菌感染疗效及安全性的系统评价
Cureus. 2022 May 31;14(5):e25537. doi: 10.7759/cureus.25537. eCollection 2022 May.
7
Infection in Liver Cirrhosis: A Concise Review.肝硬化感染：简要综述。
Can J Gastroenterol Hepatol. 2022 Jun 7;2022:4209442. doi: 10.1155/2022/4209442. eCollection 2022.
8
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience.贝左妥珠单抗治疗艰难梭菌感染：真实世界经验。
Rev Esp Quimioter. 2022 Jun;35(3):279-283. doi: 10.37201/req/120.2021. Epub 2022 Mar 14.
9
Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies.粪便微生物群移植的不良事件：高质量研究的荟萃分析。
Ann Gastroenterol. 2021 Nov-Dec;34(6):802-814. doi: 10.20524/aog.2021.0655. Epub 2021 Jul 2.
10
Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.粪便微生物移植在艰难梭菌感染和肝硬化患者中是安全有效的。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1627-1634. doi: 10.1016/j.cgh.2020.06.051. Epub 2020 Jul 6.
本文引用的文献
1
Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections.早期粪便微生物移植可改善严重艰难梭菌感染患者的生存率。
Clin Infect Dis. 2018 Feb 10;66(5):645-650. doi: 10.1093/cid/cix762.
2
Bacterial translocation markers in liver cirrhosis.肝硬化中的细菌移位标志物。
Ann Gastroenterol. 2017;30(5):486-497. doi: 10.20524/aog.2017.0178. Epub 2017 Jul 25.
3
Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.艰难梭菌感染的肝硬化住院患者的死亡预测因素
J Clin Gastroenterol. 2018 Sep;52(8):747-751. doi: 10.1097/MCG.0000000000000868.
4
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.来自合理粪便供体的粪便微生物群移植可改善肝性脑病：一项随机临床试验。
Hepatology. 2017 Dec;66(6):1727-1738. doi: 10.1002/hep.29306. Epub 2017 Oct 30.
5
Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.肝硬化患者中与肝细胞癌存在相关的肠道微生物群特征
Transplant Proc. 2016 Jun;48(5):1687-91. doi: 10.1016/j.transproceed.2016.01.077.
6
Adverse events in faecal microbiota transplant: a review of the literature.粪便微生物群移植的不良反应：文献综述。
J Hosp Infect. 2016 Feb;92(2):117-27. doi: 10.1016/j.jhin.2015.10.024. Epub 2015 Dec 15.
7
Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.建立用于治疗艰难梭菌感染的粪便微生物群移植服务。
Clin Infect Dis. 2016 Apr 1;62(7):908-14. doi: 10.1093/cid/civ994. Epub 2015 Nov 30.
8
Treating Clostridium difficile infection with fecal microbiota transplantation.粪便微生物移植治疗艰难梭菌感染。
Clin Gastroenterol Hepatol. 2011 Dec;9(12):1044-9. doi: 10.1016/j.cgh.2011.08.014. Epub 2011 Aug 24.
Zotero 插件